Evolving treatment strategies in patients with high-risk acute myeloid leukemia-Reference-Cited by-同舟云学术

Evolving treatment strategies in patients with high-risk acute myeloid leukemia

Published:2014-03-07 Issue:11 Volume:55 Page:2438-2448
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Schiller Gary J.¹

Affiliation:

1. Hematological Malignancy, Stem Cell Transplant Program, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.3109/10428194.2014.881479

Reference74 articles.

1. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

2. The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial

3. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

4. NCCN Clinical Practice Guidelines in Oncology: Acute Myeloid Leukemia. 2013; v2. Available from: www.nccn.org/professionals/physician_gls/f_guidelines.asp

5. Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress in the Treatment of AML with FLT3 Mutation;Advances in Clinical Medicine;2023

2. Miyeloid Lösemi Tedavisinde Etkili Bir İlaç Olan Midostaurinin Moleküler Kenetlenme Çalışması;Open Journal of Nano;2022-07-14

3. Using Circ-ANAPC7 as a Novel Type of Biomarker in the Monitoring of Acute Myeloid Leukemia;Acta Haematologica;2021-12-08

4. Diagnostic and prognostic relevance of serum miR-195 in pediatric acute myeloid leukemia;Cancer Biomarkers;2018-02-06

5. The impact of FLT3 mutations on treatment response and survival in Chinese de novo AML patients;Hematology;2017-09-06